ACADIA Pharmaceuticals
ACAD
#4040
Rank
$3.17 B
Marketcap
$18.37
Share price
0.49%
Change (1 day)
-22.55%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2026 (TTM): $0.15 Billion USD

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are $1.20 Billion USD. In 2025 the company made an earning of $0.13 Billion USD a decrease over its 2024 earnings that were of $0.25 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) $0.15 B13.18%
2025 $0.13 B-46.18%
2024 $0.25 B-605.67%
2023 -$51.04 Million-76.09%
2022 -$0.22 Billion27.41%
2021 -$0.17 Billion-40.38%
2020 -$0.29 Billion19.88%
2019 -$0.24 Billion-3.92%
2018 -$0.25 Billion-15.04%
2017 -$0.29 Billion6.33%
2016 -$0.28 Billion64.55%
2015 -$0.17 Billion77.47%
2014 -$92.48 Million143.69%
2013 -$37.95 Million81.93%
2012 -$20.86 Million-8.73%
2011 -$22.86 Million-251.39%
2010 $15.09 M-133.2%
2009 -$45.47 Million-30.82%
2008 -$65.73 Million6.43%
2007 -$61.76 Million25.89%
2006 -$49.06 Million36.99%
2005 -$35.81 Million37.22%
2004 -$26.1 Million19.96%
2003 -$21.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
$18.72 B 11,808.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$6.96 B 4,332.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$34.76 B 22,016.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$11.33 B 7,108.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-$0.18 Billion-213.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
-$38.63 Million-124.57%๐Ÿ‡บ๐Ÿ‡ธ USA